Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Operations (2016 - 2026)

Biomerica's Cash from Operations history spans 17 years, with the latest figure at 1250000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 1250000.0 for Q1 2026, down 19.62% from a year ago — trailing twelve months through Feb 2026 was 3170000.0 (up 24.95% YoY), and the annual figure for FY2025 was 3841000.0, up 28.35%.
  • Cash from Operations for Q1 2026 was 1250000.0 at Biomerica, down from 991000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 2358296.0 in Q1 2022 to a low of 4256046.0 in Q2 2022.
  • The 5-year median for Cash from Operations is 1045000.0 (2025), against an average of 1122514.71.
  • Peak annual rise in Cash from Operations hit 272.92% in 2022, while the deepest fall reached 2174.21% in 2022.
  • Year by year, Cash from Operations stood at 1213000.0 in 2022, then soared by 30.59% to 842000.0 in 2023, then increased by 6.06% to 791000.0 in 2024, then fell by 25.28% to 991000.0 in 2025, then dropped by 26.14% to 1250000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1250000.0, 991000.0, and 268000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.